Nova IVF Fertility is one of the most recognised fertility chains in India, with over 60 centres across major cities. For intended parents who want access to quality surrogacy care without being locked to one geography, Nova offers meaningful continuity — you can start your evaluation in Pune, do the IVF cycle in Mumbai, and manage follow-ups in Delhi without losing clinical records or having to re-explain your history.

This multi-city advantage is not just logistical convenience. It also means Nova has aggregated data from thousands of IVF and surrogacy cycles across diverse patient populations, which helps their specialists make better-informed clinical decisions.

Nova follows a standardised protocol for surrogate selection that their centres implement uniformly. Each surrogate undergoes infectious disease screening, psychological assessment, gynaecological evaluation, and legal counselling. The centre maintains a database of pre-screened altruistic surrogates as permissible under the 2021 Act.

Their embryology labs are NABH-accredited and use vitrification-based embryo freezing, which significantly improves outcomes for freeze-all cycles — increasingly the preferred approach in high-response IVF cases.

Nova’s success rates are publicly reported. For women below 35, their clinical pregnancy rate hovers around 55–62%. They are also one of the few chains that publish their IVF outcome data openly, which signals confidence in their results.

One area where Nova can improve is personalised legal counselling. Because they operate at scale, the legal guidance at some centres feels templated rather than tailored. Intended parents with complex situations may need to seek independent legal counsel in addition to what Nova provides.

Cloudnine Hospital is primarily known as a premium maternity and women’s health hospital, but its fertility division has quietly become one of the better surrogacy options in South India. What Cloudnine offers that most standalone fertility clinics cannot match is an integrated neonatal care infrastructure — once the surrogate delivers, the baby has immediate access to a Level III NICU if needed. Surrogacy babies, especially those born from IVF, sometimes arrive with complications, and having NICU support under the same roof reduces risk dramatically.

The hospital’s surrogacy programme is run in close coordination with their obstetrics and maternal-fetal medicine teams, which means the surrogate’s pregnancy is monitored with the same seriousness as a high-risk pregnancy. Foetal monitoring, anomaly scans, and gestational diabetes screenings are part of the standard protocol.

Cloudnine’s legal team has specific experience navigating Karnataka’s implementation of the Surrogacy Act. Their fertility counselling team is among the more empathetic in the country — they offer psychological support not just at the start but through every phase of the process.

Oasis Fertility has earned a reputation as one of the more accessible and transparent fertility centres in South India. Based primarily in Hyderabad, with centres in Vijayawada and Tirupati, Oasis serves a predominantly Telugu-speaking patient population — and that regional rootedness matters more than outsiders might think. Intended parents are more comfortable discussing deeply personal subjects in their own language, and Oasis has built its care model around this reality.

The centre was founded by Dr. Durga Gedela, who is well-regarded in the reproductive medicine community for her research contributions and patient-centric approach. The clinical team maintains a strong focus on evidence-based protocols, and they publish their outcome data annually — which is more transparency than most clinics offer.

Oasis also has one of the better patient education initiatives among Indian fertility centres. They conduct regular sessions — both in-person and online — where intended parents can understand the legal requirements, medical procedures, and what to realistically expect at each stage.

Milann (formerly known as BACC Healthcare’s fertility arm) is a dedicated fertility centre with a strong clinical reputation in Bengaluru and a growing presence in Delhi and Chandigarh. What distinguishes Milann is its commitment to holistic care — they treat fertility not just as a clinical problem but as something that intersects with a person’s emotional, nutritional, and psychological wellbeing.

Their surrogacy programme is built on this holistic philosophy. Intended parents receive not just medical consultations but also nutritional guidance for embryo optimisation, stress management sessions, and regular psychological support through dedicated counsellors. They are one of the few centres that actively track mental health outcomes for both intended parents and surrogates through the process.

Milann’s embryology team is led by experienced senior embryologists who have international training. Their lab uses time-lapse monitoring and pre-implantation genetic testing (PGT) as optional add-ons, valuable for families with recurrent IVF failure histories or genetic concerns.

Manipal Fertility is the fertility division of the Manipal Hospitals group, one of India’s most respected hospital networks. This hospital-backed model gives Manipal Fertility a distinct advantage: access to full hospital infrastructure, including surgical theatres, intensive care, blood banks, and specialist consultants — all under one roof.

For surrogacy, this matters because complications during pregnancy or delivery need immediate escalation pathways. At a standalone IVF clinic, a surrogate who develops preeclampsia might need emergency transfer to another hospital. At Manipal, that escalation is internal and seamless.

The fertility team has deep experience with complex cases, including recurrent implantation failure, diminished ovarian reserve, and advanced maternal age. Their genetic counselling service is well-integrated with the fertility programme, useful for families with heritable conditions.

Indira IVF is the largest IVF chain in India by number of centres, with over 130 clinics across the country. Their primary competitive advantage is reach and affordability. They have made fertility treatment accessible to families in tier-2 and tier-3 cities who would otherwise have to travel to major metros.

For surrogacy specifically, Indira IVF is a reasonable choice for families seeking a compliant, affordable pathway. Their protocols follow the 2021 Act requirements, and their centre directors in each city are familiar with state-specific district medical board procedures.

However, intended parents should go in with realistic expectations about personalisation. At this scale, the experience is somewhat standardised. Their systems are designed for volume, and while that brings down costs, it can also mean shorter consultation times and less customised treatment planning.

Fortis Bloom IVF is the fertility programme of Fortis Healthcare, one of India’s leading private hospital groups. Bloom has invested more deliberately in building a distinct identity for fertility care — it is not just the fertility wing of a hospital, it presents itself as a centre of reproductive excellence.

Fortis Bloom’s surrogacy programme places significant emphasis on pre-surrogacy investigation. Before a cycle begins, both the intended mother and the surrogate undergo extensive workups — uterine evaluation, immunological testing, and hormonal profiling. This upfront investment reduces the likelihood of failed transfers.

The hospital’s premium positioning means their costs are at the higher end, but for families who want a clearly branded, corporate-backed experience with accountability at every step, Fortis Bloom delivers.

Birla Fertility & IVF is a relatively newer entrant in the Indian fertility space, backed by the CK Birla Group — one of India’s most respected corporate conglomerates. The Birla brand brings with it a strong trust signal, and the centre has worked to back that up with genuine clinical substance.

Since launching, Birla Fertility has expanded rapidly to multiple cities, and their Delhi centres have attracted experienced fertility specialists who bring credibility to a new programme. Their lab standards are high from inception — they began with vitrification-capable embryology setups and genetic testing partnerships already in place.

The caveat is straightforward: as a newer programme, they do not yet have the multi-year outcome data that longer-established centres offer. But for families in Delhi, they represent a strong alternative to the more established names.

Cradle Fertility Centre is among the more respected fertility institutions in Chennai, serving Tamil Nadu and broader South India. For families based in Tamil Nadu, Pondicherry, or Sri Lankan Tamil diaspora families seeking care in India, Cradle offers regional expertise that generic national chains often cannot replicate.

The centre has a long-standing reputation in Chennai for sensitive handling of complex fertility cases, including unexplained infertility, poor ovarian response, and cases requiring donor eggs. Their surrogate evaluation process is meticulous about both medical and psycho-social fitness.

Cradle’s compliance with the Tamil Nadu State Medical Authority requirements under the 2021 Act is one of their operational strengths. The centre has navigated Tamil Nadu’s implementation nuances well, which can differ significantly from how states like Delhi or Maharashtra operationalise the same central law.